<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/6B75F236-A0CF-4625-A84A-0C0706188A57"><gtr:id>6B75F236-A0CF-4625-A84A-0C0706188A57</gtr:id><gtr:name>Heart of England NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Birmingham Heartlands Hospital</gtr:line1><gtr:line2>Bordesley Green East</gtr:line2><gtr:line4>Birmingham</gtr:line4><gtr:postCode>B9 5SS</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A"><gtr:id>9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A</gtr:id><gtr:name>Guy's and St Thomas' NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Westminster Bridge Road</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SE1 7EH</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2E703D46-5DDF-40CF-B8AE-371FFE8C4A70"><gtr:id>2E703D46-5DDF-40CF-B8AE-371FFE8C4A70</gtr:id><gtr:name>Birmingham Women's NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2147F96F-C607-4DBC-A602-B16069B7D082"><gtr:id>2147F96F-C607-4DBC-A602-B16069B7D082</gtr:id><gtr:name>Sandwell and West Birmingham Hospitals NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0E4C8B40-2D9E-4CCE-9A90-EF87DCB2448E"><gtr:id>0E4C8B40-2D9E-4CCE-9A90-EF87DCB2448E</gtr:id><gtr:name>Liverpool Womens NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D878FB57-FB53-44E3-A356-AE364FC540EE"><gtr:id>D878FB57-FB53-44E3-A356-AE364FC540EE</gtr:id><gtr:name>University Hospital of North Staffordshire NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A21478EA-E506-4B64-A8A9-42CD8D97C635"><gtr:id>A21478EA-E506-4B64-A8A9-42CD8D97C635</gtr:id><gtr:name>University College London Hospital (UCLH) NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5D6066EF-3116-4DB9-A313-EA86A562F928"><gtr:id>5D6066EF-3116-4DB9-A313-EA86A562F928</gtr:id><gtr:name>Imperial College Healthcare NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/67ABD4F2-1AB0-483C-9F74-C6E9B0460BF9"><gtr:id>67ABD4F2-1AB0-483C-9F74-C6E9B0460BF9</gtr:id><gtr:name>NHS Lothian</gtr:name><gtr:address><gtr:line1>Royal Victoria Hospital</gtr:line1><gtr:line2>13 Craigleith Road</gtr:line2><gtr:postCode>EH4 2DN</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A"><gtr:id>5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A</gtr:id><gtr:name>Aston University</gtr:name><gtr:department>Sch of Life and Health Sciences</gtr:department><gtr:address><gtr:line1>Aston Triangle</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:postCode>B4 7ET</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A"><gtr:id>5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A</gtr:id><gtr:name>Aston University</gtr:name><gtr:address><gtr:line1>Aston Triangle</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:postCode>B4 7ET</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6B75F236-A0CF-4625-A84A-0C0706188A57"><gtr:id>6B75F236-A0CF-4625-A84A-0C0706188A57</gtr:id><gtr:name>Heart of England NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Birmingham Heartlands Hospital</gtr:line1><gtr:line2>Bordesley Green East</gtr:line2><gtr:line4>Birmingham</gtr:line4><gtr:postCode>B9 5SS</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A"><gtr:id>9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A</gtr:id><gtr:name>Guy's and St Thomas' NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Westminster Bridge Road</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SE1 7EH</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2E703D46-5DDF-40CF-B8AE-371FFE8C4A70"><gtr:id>2E703D46-5DDF-40CF-B8AE-371FFE8C4A70</gtr:id><gtr:name>Birmingham Women's NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2147F96F-C607-4DBC-A602-B16069B7D082"><gtr:id>2147F96F-C607-4DBC-A602-B16069B7D082</gtr:id><gtr:name>Sandwell and West Birmingham Hospitals NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0E4C8B40-2D9E-4CCE-9A90-EF87DCB2448E"><gtr:id>0E4C8B40-2D9E-4CCE-9A90-EF87DCB2448E</gtr:id><gtr:name>Liverpool Womens NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D878FB57-FB53-44E3-A356-AE364FC540EE"><gtr:id>D878FB57-FB53-44E3-A356-AE364FC540EE</gtr:id><gtr:name>University Hospital of North Staffordshire NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A21478EA-E506-4B64-A8A9-42CD8D97C635"><gtr:id>A21478EA-E506-4B64-A8A9-42CD8D97C635</gtr:id><gtr:name>University College London Hospital (UCLH) NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5D6066EF-3116-4DB9-A313-EA86A562F928"><gtr:id>5D6066EF-3116-4DB9-A313-EA86A562F928</gtr:id><gtr:name>Imperial College Healthcare NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/67ABD4F2-1AB0-483C-9F74-C6E9B0460BF9"><gtr:id>67ABD4F2-1AB0-483C-9F74-C6E9B0460BF9</gtr:id><gtr:name>NHS Lothian</gtr:name><gtr:address><gtr:line1>Royal Victoria Hospital</gtr:line1><gtr:line2>13 Craigleith Road</gtr:line2><gtr:postCode>EH4 2DN</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C32E9430-021D-4676-85DE-838CD7B384A0"><gtr:id>C32E9430-021D-4676-85DE-838CD7B384A0</gtr:id><gtr:firstName>Asif</gtr:firstName><gtr:surname>Ahmed</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0701824"><gtr:id>C8A056A8-776A-48D6-ADCE-4C1FBC9E4B5D</gtr:id><gtr:title>A Proof of Principle Randomised Placebo-Controlled Trial for Use of Statins to Ameliorate Early Onset Preeclampsia</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701824</gtr:grantReference><gtr:abstractText>Preeclampsia (PE) is a potentially dangerous condition of pregnancy in which the mother?s blood pressure is higher than normal and there is protein in the urine. About 1 in 100 women experience preeclampsia before 32 weeks of pregnancy. The only effective treatment is to deliver the baby prematurely, but this has serious consequences for the baby. Watchful waiting, often employed clinically to allow the baby?s lungs to mature, risks progression of disease severity in the mother. A cheap and effective therapy for prevention of preeclampsia complications is urgently needed.

It is not known what causes preeclampsia but recently some blood molecules (called anti-angiogenic factors) known to affect blood flow are higher in women with PE. These anti-angiogenic factors when given to pregnant animals mimic preeclampsia. Drugs called statins, which lower cholesterol, reduce the levels of these molecules. It is not known whether statins can reduce the severity and complications of preeclampsia.

We will test the idea that statins can reduce these molecules in preeclamptic women before 32 weeks of pregnancy and decrease the severity of preeclampsia. Doctors from six hospitals will seek consent from these women. Those who are suitable and agree, will be randomly divided into two groups. One group will get a daily dose of statin. The other will get a dummy sugar pill (placebo). We hope to recruit 128 women. Neither the women nor their doctors will know what group they are in. In this way, we can be confident that any differences between the two groups are due to treatment. Women will stay in hospital and be closely monitored, and if the preeclampsia gets worse, their baby will be delivered.

This trial is unique because it is the first to test whether statins can reduce the severity of preeclampsia and because statins are not prescribed normally to pregnant women. There is some concern that statins may cause congenital defects in the baby, but we have found no convincing evidence to support this. Furthermore, we believe it is safe to give statins later in pregnancy once the baby?s organs have already developed. However, all side effects and complications will be closely monitored.

If this small trial shows that the severity of preeclampsia is reduced, and there are few side effects, a bigger trial will be organised to determine if statins can increase the length of pregnancy and reduce the number of premature deliveries.</gtr:abstractText><gtr:technicalSummary>Preeclampsia (PE) is a systemic endothelial disease characterised by hypertension, proteinuria, exacerbated inflammation, dysregulated angiogenesis and can lead to morbidity and mortality in both mother and baby. Currently the only effective treatment for PE is delivery of the baby. However, early delivery, especially before 32 weeks gestation, often has serious consequences for the health of the baby. A cheap and effective therapy for prevention of PE complications is urgently needed. Increasing evidence shows that excess circulating soluble Flt-1 (sFlt-1) plays a role in the pathogenesis of PE. We showed that statins (HMG-CoA reductase inhibitors), a class of lipid-lowering drugs, inhibit cytokine-mediated release of sFlt-1 in ex vivo human placental model. This IES platform will test the hypothesis that statin use during early onset PE would lead to a significant reduction of sFlt-1 and alleviate the severity of PE. We will undertake a proof of principle randomised placebo-controlled multi-centre RCT trial for use of statins to ameliorate early onset PE. A minimum of 128 pregnancies will be randomised from six maternity units in the UK. Minimum inclusion clinical criteria will be gestational age range of 24-32 weeks with new onset hypertension; systolic 140mmHg and diastolic 90mmHg; Protein/creatinine ratio 30mg/mmol or 300mg proteinuria/24 hours. Consenting mothers will be randomised to receive either 40mg pravastatin capsules once a day or identical placebo until delivery with conservative management of their PE. The primary outcome measures will be changes in plasma levels of biomarkers (sFlt-1/sEng/PlGF). Secondary outcomes measures will be severity of PE, prolongation of pregnancy post treatment, maternal and neonatal outcomes and adverse effects. We will also formally assess the feasibility of a definitive trial by examining recruitment rates, compliance and physcian and patient readiness for randomisaiton to statins. This study will identify a novel intervention based on strong scientific rationale, which will inform a future large-scale multi-centre randomised trial.</gtr:technicalSummary><gtr:fund><gtr:end>2014-07-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>625244</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Liverpool Womens NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Liverpool Women's Hospital</gtr:department><gtr:description>Trial Centres</gtr:description><gtr:id>5C756BB1-78BE-4A94-9B5B-8668BA0FCC66</gtr:id><gtr:impact>This is too early to report.</gtr:impact><gtr:partnerContribution>Recruitment of patients to StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trial</gtr:partnerContribution><gtr:piContribution>We have coordinated and pooled all these centres to work with us on this trial.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Heart of England NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Trial Centres</gtr:description><gtr:id>B6685CE6-723A-495B-9397-2C65424F5DD6</gtr:id><gtr:impact>This is too early to report.</gtr:impact><gtr:partnerContribution>Recruitment of patients to StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trial</gtr:partnerContribution><gtr:piContribution>We have coordinated and pooled all these centres to work with us on this trial.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital of North Staffordshire NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Trial Centres</gtr:description><gtr:id>28BAFB0E-A91C-4B90-875B-A28597C03B71</gtr:id><gtr:impact>This is too early to report.</gtr:impact><gtr:partnerContribution>Recruitment of patients to StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trial</gtr:partnerContribution><gtr:piContribution>We have coordinated and pooled all these centres to work with us on this trial.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Birmingham Women's NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Birmingham Women's Hospital</gtr:department><gtr:description>Trial Centres</gtr:description><gtr:id>32FD1A75-95F0-4531-9F84-B890748DB4BD</gtr:id><gtr:impact>This is too early to report.</gtr:impact><gtr:partnerContribution>Recruitment of patients to StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trial</gtr:partnerContribution><gtr:piContribution>We have coordinated and pooled all these centres to work with us on this trial.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sandwell and West Birmingham Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Trial Centres</gtr:description><gtr:id>16001D3F-44A1-4A62-B667-3C731FF960E1</gtr:id><gtr:impact>This is too early to report.</gtr:impact><gtr:partnerContribution>Recruitment of patients to StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trial</gtr:partnerContribution><gtr:piContribution>We have coordinated and pooled all these centres to work with us on this trial.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Guy's and St Thomas' NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Trial Centres</gtr:description><gtr:id>51A1A9CF-679F-4FF6-9014-1F962C9A06DC</gtr:id><gtr:impact>This is too early to report.</gtr:impact><gtr:partnerContribution>Recruitment of patients to StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trial</gtr:partnerContribution><gtr:piContribution>We have coordinated and pooled all these centres to work with us on this trial.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College Healthcare NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Trial Centres</gtr:description><gtr:id>83C74151-BC82-4029-996C-D4310B0781BB</gtr:id><gtr:impact>This is too early to report.</gtr:impact><gtr:partnerContribution>Recruitment of patients to StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trial</gtr:partnerContribution><gtr:piContribution>We have coordinated and pooled all these centres to work with us on this trial.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Newcastle</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Newcastle University Teaching Hospitals</gtr:department><gtr:description>Trial Centres</gtr:description><gtr:id>4833F380-B62F-4B05-8975-E23638AF728A</gtr:id><gtr:impact>This is too early to report.</gtr:impact><gtr:partnerContribution>Recruitment of patients to StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trial</gtr:partnerContribution><gtr:piContribution>We have coordinated and pooled all these centres to work with us on this trial.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Trial Centres</gtr:description><gtr:id>50A86CB6-93BF-4A1F-9BE3-C0720CD7BECB</gtr:id><gtr:impact>This is too early to report.</gtr:impact><gtr:partnerContribution>Recruitment of patients to StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trial</gtr:partnerContribution><gtr:piContribution>We have coordinated and pooled all these centres to work with us on this trial.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS Lothian</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Trial Centres</gtr:description><gtr:id>21488FE6-6047-472E-A2BC-3EF843A6BECB</gtr:id><gtr:impact>This is too early to report.</gtr:impact><gtr:partnerContribution>Recruitment of patients to StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmp trialRecruitment of patients to the StAmP trialRecruitment of patients to the StAmP trial</gtr:partnerContribution><gtr:piContribution>We have coordinated and pooled all these centres to work with us on this trial.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>The Sun</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>761A350E-197C-4408-B003-C65709B34567</gtr:id><gtr:impact>&amp;quot;Drugs to save tots&amp;quot; was the headline.

N/A</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Daily Express</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>633E67F4-23D3-4E7A-8A0B-BEB389A5DBDE</gtr:id><gtr:impact>Heart disease drug that could help beat deadly disease in mums-to-be

N/A</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Regional News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2FC9B5F0-233D-433A-A9D9-A919018E60A7</gtr:id><gtr:impact>BBC Regional News (TV) - Other UK
Place duration: 3:14
Date of coverage 20/04/11

Patients called to learn more about the trial and when they could see benefits</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Central FM</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6C867317-EBEC-4757-82AC-69E72E0FD968</gtr:id><gtr:impact>Heart disease trials



N/A</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Daily Mail</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A63D5F97-F5C3-4695-96B8-6EE9CC535A1C</gtr:id><gtr:impact>Heart pill may help slash the pregnancy death toll

contacted by public following this</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Daily Telegraph</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>19C9DC59-117C-4530-B598-1CA237F5993B</gtr:id><gtr:impact>Statins could treat pregnant women at risk of fatal condition

increased public awareness for the condition of preeclampsia</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>STV</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8000DCD0-90EC-4642-AB7F-26AD37954C94</gtr:id><gtr:impact>5-7 min feature news

N/A</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>Health Technology Assessment programme</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:id>42D629C1-BF9C-464D-9ED3-DA2F807BAADC</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Rationale for statin use in preeclampsia</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9FBA0544-CA71-487B-A383-CB8102749A86</gtr:id><gtr:impact>Biotech are making contact to take our approach to therapy.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Established collaboration and obtained joint MRC Strategic funds in Translational Medicine. However, Abbott Diagnostics Inc. later pulled out due to financial downturn.</gtr:description><gtr:id>AD219111-ECB7-45C2-B8F7-B45268D02B70</gtr:id><gtr:impact>Potentially it could lead to early diagnosis of preeclampsia which will allow StAmP trial output to provide a potential treatment for such patients.</gtr:impact><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Closed</gtr:status><gtr:title>Abbott Diagnostics Inc.</gtr:title><gtr:type>Therapeutic Intervention - Medical Devices</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Statins for use in Preeclampsia</gtr:description><gtr:id>F03A1CD3-1A25-4549-B070-8299D74A435E</gtr:id><gtr:impact>World's first RCT underway. - StAmP.</gtr:impact><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>StAmP</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2008</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have identified potentially a new biomarker using our mouse model, which we are planing to test in our human population samples.</gtr:description><gtr:id>690007A5-5B29-4A15-A757-DB805C1BF3FE</gtr:id><gtr:impact>Too early to talk about it as its too preliminary.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PreDict</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0ED7B573-DB0D-4C8F-A8C8-D2FC264CEAFA"><gtr:id>0ED7B573-DB0D-4C8F-A8C8-D2FC264CEAFA</gtr:id><gtr:title>Is inflammation the cause of pre-eclampsia?</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9463437bd7e5cb2602492c65f758bf0f"><gtr:id>9463437bd7e5cb2602492c65f758bf0f</gtr:id><gtr:otherNames>Ramma W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/712CAB1C-346D-430E-A5E5-DFEC1C417DE3"><gtr:id>712CAB1C-346D-430E-A5E5-DFEC1C417DE3</gtr:id><gtr:title>Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dce14b357c7844c03c8a3040606b07d8"><gtr:id>dce14b357c7844c03c8a3040606b07d8</gtr:id><gtr:otherNames>Rosenberg VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5A60975F-F4C0-47EF-9A3E-71F4AC0B9B64"><gtr:id>5A60975F-F4C0-47EF-9A3E-71F4AC0B9B64</gtr:id><gtr:title>The role of H2S bioavailability in endothelial dysfunction.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/17f6633e9d8a0b4804343fbc2df4165c"><gtr:id>17f6633e9d8a0b4804343fbc2df4165c</gtr:id><gtr:otherNames>Wang R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FF983A21-AA1E-48B2-A4C5-97970337E789"><gtr:id>FF983A21-AA1E-48B2-A4C5-97970337E789</gtr:id><gtr:title>Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm?</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5b268a5b4f18e012b49c9c4df08170ee"><gtr:id>5b268a5b4f18e012b49c9c4df08170ee</gtr:id><gtr:otherNames>Ahmed A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C5738B4C-2C98-4DAA-904D-AB82BD9B7C31"><gtr:id>C5738B4C-2C98-4DAA-904D-AB82BD9B7C31</gtr:id><gtr:title>Antenatal corticosteroids impact the inflammatory rather than the antiangiogenic profile of women with preeclampsia.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/540a43394e95f123344bacc64246ed15"><gtr:id>540a43394e95f123344bacc64246ed15</gtr:id><gtr:otherNames>Nayeri UA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5E41D08F-3539-45EC-B692-A07B338A20F9"><gtr:id>5E41D08F-3539-45EC-B692-A07B338A20F9</gtr:id><gtr:title>Dysregulation of hydrogen sulfide producing enzyme cystathionine ?-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5f5948b5a7f162e349b3184da5420ba0"><gtr:id>5f5948b5a7f162e349b3184da5420ba0</gtr:id><gtr:otherNames>Wang K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/57083B40-4260-4D76-A1BC-1001B99EF433"><gtr:id>57083B40-4260-4D76-A1BC-1001B99EF433</gtr:id><gtr:title>Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba033bc7077768019119d506b1113191"><gtr:id>ba033bc7077768019119d506b1113191</gtr:id><gtr:otherNames>Wegiel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B0ADC6FF-62E0-4E74-ACF5-41C82599F976"><gtr:id>B0ADC6FF-62E0-4E74-ACF5-41C82599F976</gtr:id><gtr:title>The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia.</gtr:title><gtr:parentPublicationTitle>Angiogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9463437bd7e5cb2602492c65f758bf0f"><gtr:id>9463437bd7e5cb2602492c65f758bf0f</gtr:id><gtr:otherNames>Ramma W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-6970</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701824</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>